We use own cookies and thirds to offer you better service More information Accept
Back to News

Nov. 2017

Qualigen launches Premax, the only Pregabalin tablets of the Spanish market

Premax tablets, the new singular drug of Qualigen for the neuropathic pain

2nd November 2017.- Qualigen is launching Premax 25 mg, 75 mg, 150 mg and 300 mg tablets EFG, the only Pregabalin in scored tablets in Spain.

Premax tablets EFG, a medicine developed entirely at a national level, comes in a different dosage form than the reference drug in capsules, which makes it unique:

-The scored tablets are the result of requests from prescribers to facilitate the intake and the accomplishment of the treatment.

-The single-dose packaging facilitates hospital management and avoids administration errors.

Premax, whose active ingredient is Pregabalin, is bioequivalent to Pfizer's Lyrica® and is suitable for peripheral and central neuropathic pain, for the treatment of epilepsy, as well as for treating generalized anxiety disorder (GAD) in adults.

Premax tablets EFG is marketed in four presentations of 56 tablets of 25 mg, 75 mg, 150 mg and 300 mg, which are administered orally.

Premax tablets EFG requires a prescription for dispensing and is financed by the Spanish Health System with reduced contribution.

With this new launch, Qualigen strengthens its position as a laboratory with a large product portfolio of drugs for disorders related to the central nervous system: antidepressants, antipsychotics, antiepileptics, antiparkinsonians, anxiolytics, hypnotics and for the treatment of Alzheimer.